Consolidation Therapy with Bortezomib/Lenalidomide/Dexamethasone Versus Bortezomib/Dexamethasone After a Dexamethasone-Based Induction Regimen in Patients with Multiple Myeloma: A Randomized Phase III Trial

Bortezomib-Cyclophosphamide-Dexamethason

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) versus Bortezomib-Thalidomide-Dexamethasone (VTD) -based regimens as induction therapies in newly diagnosed transplant eligible patients with multiple myeloma: a meta-analysis

✍ Leiba, Merav; Kedmi, Meirav; Duek, Adrian; Freidman, Tzachi; Weiss, Mia; Leiba, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Bortezomib-Cyclophosphamide-Dexamethason

Bortezomib-Cyclophosphamide-Dexamethasone (VCD) versus Bortezomib-Thalidomide-Dexamethasone (VTD) -based regimens as induction therapies in newly diagnosed transplant eligible patients with multiple myeloma: a meta-analysis

✍ Leiba, Merav; Kedmi, Meirav; Duek, Adrian; Freidman, Tzachi; Weiss, Mia; Leiba, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Consolidation and maintenance therapy wi

Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients

✍ Nooka, A K; Kaufman, J L; Muppidi, S; Langston, A; Heffner, L T; Gleason, C; Cas 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 633 KB

A phase 2 trial of lenalidomide, bortezo

A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

✍ Richardson, P. G.; Xie, W.; Jagannath, S.; Jakubowiak, A.; Lonial, S.; Raje, N. 📂 Article 📅 2014 🏛 American Society of Hematology 🌐 English ⚖ 510 KB

Bortezomib with thalidomide plus dexamet

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

✍ Michele Cavo; Paola Tacchetti; Francesca Patriarca; Maria Teresa Petrucci; Lucia 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 276 KB

Sequential vincristine, adriamycin, dexa

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial

✍ Hye Jin Kim; Sung-Soo Yoon; Dong Soon Lee; Sang Kyun Sohn; Hyeon Seok Eom; Jung 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 184 KB